Clinical Trials Details

Adjuvant Lung Cancer Enrichment Mark Identification and Sequencing Trial (ALCHEMIST) (Alliance A151216)

Study Details

This phase III ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

Learn More NCT number

Principal Investigators

  • Salvatore Del Prete, MD
Alliance for Clinical Trials in Oncology
Ed Hatton, RN at 203-358-8879


  • Bennett Cancer Center
    One Hospital Plaza
    Stamford, CT 06902
    Main: 203-276-2695